^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Cvac (cancer vaccine MUC-1)

    i
    Associations
    News

    Trials

    Company:
    Immutep, Sydys Corp
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    Ovarian Cancer Vaccine for Patients in Remission (NCT01068509)
    Phase 2b
    Prima BioMed Ltd
    Completed
    Last update posted :
    05/11/2017
    Initiation :
    07/01/2010
    Primary completion :
    08/01/2013
    Completion :
    04/01/2015
    MUC16
    |
    MUC16 elevation
    |
    Cvac (cancer vaccine MUC-1)